Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.59 USD | +3.60% | +1.57% | -20.06% |
Mar. 21 | Earnings Flash (ARMP) ARMATA PHARMACEUTICALS Reports Q4 Revenue $1.5M | MT |
Mar. 21 | Armata Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.06% | 90.37M | |
+0.64% | 43.84B | |
+4.73% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+5.84% | 25.53B | |
-25.63% | 18.18B | |
-3.88% | 12.29B | |
+25.31% | 12.29B | |
+6.84% | 11.15B |
- Stock Market
- Equities
- ARMP Stock
- News Armata Pharmaceuticals, Inc.
- Insider Trends: 90-Day Buying Trend Extended with Insider Purchase of Armata Pharmaceuticals Stock